Evidence-based research overwhelmingly shows the need for more and higher-quality doctor-patient conversations.
Congress created the 340B program to give eligible healthcare providers financial relief from high prescription drug prices.
Federal policy is now disproportionately slashing support for hospitals that serve the nation’s poor.
Left unencumbered, domestic medical innovation will generate the new treatments that can help drive down long-term healthcare costs.
CMS should reverse course and adopt separate HSPCS J-codes for each biosimilar.
The Affordable Care Act created an overdue pathway for generic versions of biologics, called biosimilars.
Clearly an incentive is needed to motivate companies to enter into the biodefense realm.
About 700 kids under the age of 18 become regular smokers each day.
The ACA is further compounding funding problems for the nation’s nursing homes.
Congress has not modernized FDA’s organizational structure for medical products since the 1970s.